{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459527095
| ImageFile=Befloxatone structure.svg
| ImageSize = 250
| IUPACName=(''R'')-5-(methoxymethyl)-3-(4-((''R'')-4,4,4-trifluoro-3-hydroxybutoxy)phenyl)-oxazolidin-2-one
| OtherNames=
|Section1={{Chembox Identifiers
| IUPHAR_ligand = 6637
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54811
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 416578
| InChI = 1/C15H18F3NO5/c1-22-9-12-8-19(14(21)24-12)10-2-4-11(5-3-10)23-7-6-13(20)15(16,17)18/h2-5,12-13,20H,6-9H2,1H3/t12-,13-/m1/s1
| InChIKey = IALVDLPLCLFBCF-CHWSQXEVBB
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI=1S/C15H18F3NO5/c1-22-9-12-8-19(14(21)24-12)10-2-4-11(5-3-10)23-7-6-13(20)15(16,17)18/h2-5,12-13,20H,6-9H2,1H3/t12-,13-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IALVDLPLCLFBCF-CHWSQXEVSA-N
| CASNo_Ref = {{cascite|changed|??}}
| CASNo=134564-82-2
| PubChem=60824
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG= D02563
| SMILES = O=C2O[C@H](CN2c1ccc(OCC[C@@H](O)C(F)(F)F)cc1)COC
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4H75PAD8M3
}}
|Section2={{Chembox Properties
| Formula=C<sub>15</sub>H<sub>18</sub>F<sub>3</sub>NO<sub>5</sub>
| MolarMass=349.30233
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
}}
|Section3={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
}}
}}

'''Befloxatone''' (MD-370,503) is a [[reversible inhibitor of monoamine oxidase A]].<ref>{{cite journal|last=Emilien|first=G|title=Befloxatone (Synthelabo)|journal=IDrugs|date=March 1999|volume=2|issue=3|pages=247–253|pmid=16160936}}</ref><ref>{{cite journal|first1=Dominique|last1=Warot|last2=Berlin|first2=Ivan|last3=Patat|first3=Alain|last4=Durrieu|first4=Geneviève|last5=Zieleniuk|first5=Isabelle|last6=Puech|first6=Alain J|title=Effects of Befloxatone, a Reversible Selective Monoamine Oxidase-A Inhibitor, on Psychomotor Function and Memory in Healthy Subjects|journal=The Journal of Clinical Pharmacology|date=October 1996|volume=36|series=1552-4604|issue=10|pages=942–950|doi=10.1002/j.1552-4604.1996.tb04762.x|pmid=8930782|url=https://dx.doi.org/10.1002/j.1552-4604.1996.tb04762.x|publisher=Blackwell Publishing Ltd.}}</ref> 

==References==
{{Reflist}}


{{Monoamine metabolism modulators}}

[[Category:Monoamine oxidase inhibitors]]
[[Category:Trifluoromethyl compounds]]
[[Category:Alcohols]]
[[Category:Phenol ethers]]
[[Category:Oxazolidinones]]
[[Category:Carbamates]]
[[Category:Ethers]]


{{nervous-system-drug-stub}}